Bacil Pharma has informed that it attached certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2022 received from Registrar and Transfer Agent of the Company - ‘Big share Services’.
The above information is a part of company’s filings submitted to BSE.